<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front numbers represent salvage LT for HCC within Milan criteria and the numbers at the back represent the salvage LT for HCC beyond Milan but within UCSF criteria).</p
<p>Kaplan–Meier estimates of overall survival between patients with locoregional recurrence and thos...
Comparison of clinical features among patients in the survival and death subgroups of the verificati...
<p>Comparison of overall and HCC-specific survival between patients with EHPC and patients without E...
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>The overall survival and recurrence-free survival rates of patients who fit the Milan, Milan-UCSF...
<p>Comparison of the 1- and 3- year survival rates between group L and group H (A); Excluding HCC re...
<p>(A) shows the cumulative recurrence rate between SLT group and PLTW group, a Log-Rank test showed...
<p>(A) shows the cumulative survival rate between SLT group and PLTW group, a Log-Rank test showed <...
<p>Comparison of the 1- and 3- year survival rates among group LS, LN, HS, and HN (A); Excluding HCC...
<p><b>A,</b> Survival curves of patients with different sT categories. <b>B,</b> Survival curves of ...
<p>There is a significant difference in OS between recipients fulfilling Hangzhou/Milan criteria and...
<p>There is a significant difference in TFS between recipients fulfilling Hangzhou/Milan criteria an...
Kaplan-Meier survival curves comparing in-patient survival probabilities between liver cirrhosis pat...
<p>Kaplan–Meier estimates of overall survival between patients with locoregional recurrence and thos...
Comparison of clinical features among patients in the survival and death subgroups of the verificati...
<p>Comparison of overall and HCC-specific survival between patients with EHPC and patients without E...
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>Numbers in parentheses indicate patients at risk at beginning of each time interval (the front nu...
<p>The overall survival and recurrence-free survival rates of patients who fit the Milan, Milan-UCSF...
<p>Comparison of the 1- and 3- year survival rates between group L and group H (A); Excluding HCC re...
<p>(A) shows the cumulative recurrence rate between SLT group and PLTW group, a Log-Rank test showed...
<p>(A) shows the cumulative survival rate between SLT group and PLTW group, a Log-Rank test showed <...
<p>Comparison of the 1- and 3- year survival rates among group LS, LN, HS, and HN (A); Excluding HCC...
<p><b>A,</b> Survival curves of patients with different sT categories. <b>B,</b> Survival curves of ...
<p>There is a significant difference in OS between recipients fulfilling Hangzhou/Milan criteria and...
<p>There is a significant difference in TFS between recipients fulfilling Hangzhou/Milan criteria an...
Kaplan-Meier survival curves comparing in-patient survival probabilities between liver cirrhosis pat...
<p>Kaplan–Meier estimates of overall survival between patients with locoregional recurrence and thos...
Comparison of clinical features among patients in the survival and death subgroups of the verificati...
<p>Comparison of overall and HCC-specific survival between patients with EHPC and patients without E...